Skip to main content
Top
Published in: Cancer Causes & Control 8/2009

01-10-2009 | Letter to the Editor

Reply to: Dr. Peter Morfeld’s Letter to the Editor (Manuscript Number: CACO2009): “Comment on Lacasse Y, Martin S, Gagne D, Lakhal L (2009) Dose–response meta-analysis of silica and lung cancer. Cancer Causes and Control; [e-pub ahead of print] doi: 10.1007/s10552-009-9296-0”

Authors: Lajmi Lakhal, Yves Lacasse

Published in: Cancer Causes & Control | Issue 8/2009

Login to get access

Excerpt

To the editor, …
Metadata
Title
Reply to: Dr. Peter Morfeld’s Letter to the Editor (Manuscript Number: CACO2009): “Comment on Lacasse Y, Martin S, Gagne D, Lakhal L (2009) Dose–response meta-analysis of silica and lung cancer. Cancer Causes and Control; [e-pub ahead of print] doi: 10.1007/s10552-009-9296-0”
Authors
Lajmi Lakhal
Yves Lacasse
Publication date
01-10-2009
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 8/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9361-8

Other articles of this Issue 8/2009

Cancer Causes & Control 8/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine